We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VBTX
1726
DELISTED
Veritex Holdings
VBTX
| $1.34M | ﹤0.01% |
65,444
+11,911
| +22% | +$246K |
|
|
PRFT
1727
DELISTED
Perficient Inc
PRFT
| $1.34M | ﹤0.01% |
+23,805
| New | +$1.56M |
|
1728
Under Armour
UAA
$2.6B
| $1.34M | ﹤0.01% |
181,183
-512,252
| -74% | -$4.08M |
|
1729
National Vision
EYE
$1.81B
| $1.34M | ﹤0.01% |
60,316
-4,355
| -7% | -$91.8K |
|
1730
Organogenesis Holdings
ORGO
$239M
| $1.33M | ﹤0.01% |
469,850
-87,203
| -16% | -$296K |
|
|
UCFI
1731
CN Healthy Food Tech Group
UCFI
| $1.33M | ﹤0.01% |
+133,437
| New | +$1.33M |
|
1732
ESCO Technologies
ESE
$7.92B
| $1.33M | ﹤0.01% |
12,400
+7,500
| +153% | +$769K |
|
1733
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.9B
| $1.33M | ﹤0.01% |
15,000
+11,800
| +369% | +$1.01M |
|
1734
ICICI Bank
IBN
$108B
| $1.32M | ﹤0.01% |
50,159
-37,818
| -43% | -$944K |
|
|
TDCX
1735
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $1.32M | ﹤0.01% |
184,018
-44,150
| -19% | -$290K |
|
1736
Daktronics
DAKT
$1.04B
| $1.32M | ﹤0.01% |
132,134
-39,063
| -23% | -$326K |
|
|
BUJA
1737
DELISTED
Bukit Jalil Global Acquisition 1
BUJA
| $1.31M | ﹤0.01% |
125,000
| – | – |
|
1738
Travelers Companies
TRV
$80.2B
| $1.31M | ﹤0.01% |
5,703
-67,405
| -92% | -$14.4M |
|
1739
Forward Air
FWRD
$654M
| $1.31M | ﹤0.01% |
41,983
-43,246
| -51% | -$1.81M |
|
1740
AT&T
T
$163B
| $1.29M | ﹤0.01% |
73,200
-272,857
| -79% | -$4.66M |
|
1741
JetBlue
JBLU
$2.29B
| $1.29M | ﹤0.01% |
173,463
+29,437
| +20% | +$183K |
|
1742
Graham Holdings Company
GHC
$5.02B
| $1.28M | ﹤0.01% |
1,673
-1,493
| -47% | -$1.07M |
|
1743
iShares US Oil & Gas Exploration & Production ETF
IEO
$543M
| $1.28M | ﹤0.01% |
12,000
-49,400
| -80% | -$4.7M |
|
1744
Resources Connection
RGP
$145M
| $1.28M | ﹤0.01% |
97,219
-72,898
| -43% | -$974K |
|
|
GBIO
1745
DELISTED
Generation Bio
GBIO
| $1.28M | ﹤0.01% |
31,415
-293
| -0.9% | -$6.9K |
|
1746
Americold
COLD
$4.27B
| $1.28M | ﹤0.01% |
51,222
+42,822
| +510% | +$1.17M |
|
1747
Ciena
CIEN
$58.4B
| $1.28M | ﹤0.01% |
25,800
-370,748
| -93% | -$19.6M |
|
1748
Peapack-Gladstone Financial
PGC
$812M
| $1.27M | ﹤0.01% |
52,337
+27,865
| +114% | +$713K |
|
|
UGIC
1749
DELISTED
UGI Corporation
UGIC
| $1.27M | ﹤0.01% |
21,900
| – | – |
|
1750
Transportadora de Gas del Sur
TGS
$4.33B
| $1.27M | ﹤0.01% |
84,300
-6,160
| -7% | -$85.8K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.